financetom
Business
financetom
/
Business
/
Strategic Education Insider Bought Shares Worth $477,950, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Strategic Education Insider Bought Shares Worth $477,950, According to a Recent SEC Filing
Aug 5, 2024 5:35 AM

08:07 AM EDT, 08/05/2024 (MT Newswires) -- Viet D Dinh, Director, on August 02, 2024, executed a purchase for 5,000 shares in Strategic Education ( STRA ) for $477,950. Following the Form 4 filing with the SEC, Dinh has control over a total of 20,020 shares of the company, with 20,020 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1013934/000141588924020702/xslF345X03/form4-08052024_110811.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Gladstone Commercial Acquires Missouri Industrial Manufacturing, Distribution, Warehouse Facility
Gladstone Commercial Acquires Missouri Industrial Manufacturing, Distribution, Warehouse Facility
Nov 19, 2024
09:20 AM EST, 11/18/2024 (MT Newswires) -- Gladstone Commercial ( GOOD ) said Monday it acquired a 124,500-square foot industrial manufacturing, distribution and warehouse facility in Missouri. The real estate investment trust said it acquired the property in St. Clair subject to a 20-year absolute triple net lease to ATRO. Gladstone shares were up 3% in premarket activity. ...
US Supreme Court declines to hear patent dispute over Bausch blockbuster diarrhea drug
US Supreme Court declines to hear patent dispute over Bausch blockbuster diarrhea drug
Nov 19, 2024
* Lower court found Norwich generic infringes Salix patents * Alvogen has Xifaxan generic deals with Teva, Sun, Sandoz By Blake Brittain WASHINGTON, Nov 18 (Reuters) - The U.S. Supreme Court turned away on Monday a bid by Alvogen's subsidiary Norwich Pharmaceuticals to sell a generic version of Canada-based Bausch Health's ( BHC ) blockbuster diarrhea drug Xifaxan. The justices...
Aclaris Therapeutics Signs License Agreement with Chinese Biotech Biosion
Aclaris Therapeutics Signs License Agreement with Chinese Biotech Biosion
Nov 19, 2024
09:43 AM EST, 11/18/2024 (MT Newswires) -- Aclaris Therapeutics ( ACRS ) said Monday that it has acquired global development rights outside of China for potential anti-TSLP monoclonal and bispecific antibodies directed against both TSLP and IL4R developed by Chinese biotech firm Biosion. The license agreement states that Biosion will receive more than $40 million in cash from Aclaris as...
Market Chatter: Canada's Brookfield Reportedly Plans to Offer About 7-billion Euros For Spanish drugmaker Grifols
Market Chatter: Canada's Brookfield Reportedly Plans to Offer About 7-billion Euros For Spanish drugmaker Grifols
Nov 19, 2024
09:25 AM EST, 11/18/2024 (MT Newswires) -- Canadian fund Brookfield (BN.TO) plans to offer about 7-billion euros ($7.4-billion) for Spanish drugmaker Grifols after finishing due diligence, news website El Confidencial reported on Monday, citing sources close to the matter. This is a Reuters report published on the website of The Globe and Mail newspaper. Brookfield is evaluating offering 10.5 euros...
Copyright 2023-2026 - www.financetom.com All Rights Reserved